DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

Gilead Sciences (NASDAQ: GILD)

company name or ticker
Company Photos
(Click to zoom)

The Most Important Message From Charlie Sheen's Recent HIV Admission

Charlie Sheen stunned the world with his HIV admission, but there's a far bigger lesson behind this announcement.

3 Healthcare Stocks With Massive Buyback Programs

These company's are spending billions of dollars repurchasing their shares, and that may not be a bad thing.

Stock Market News for November 27, 2015

The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros

Giving Thanks, Healthcare Style

Giving thanks and recognizing the heroes of the healthcare industry.

5 Dividend Stocks to Buy in December

Dividends can be a powerful tool for investors to generate wealth over time.

Jeremy Grantham's Holdings Trading Below Peter Lynch Earnings Line

Gilead Sciences Grabs 4 Regulatory Wins -- but Does It Matter?

Gilead Sciences has announced four new regulatory approvals since the start of the quarter, but will they move the company's financials?

My Black Friday Specials

Gilead Sciences Stock Forecast For 2016

See More Articles...